LCO No. 1702 1 of 2
General Assembly Proposed Bill No. 758
January Session, 2025
LCO No. 1702
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
SEN. ANWAR, 3rd Dist.
SEN. MARTIN, 31st Dist.
AN ACT CONCERNING PHARMACY BENEFITS MANAGER REFORM.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
That title 38a of the general statutes be amended to: (1) Prohibit any 1
pharmacy benefits manager from imposing post-transaction fees or 2
implementing reimbursement clawbacks on pharmacies; (2) require that 3
any rebate, discount or financial incentive provided by any drug 4
manufacturer to any pharmacy benefits manager be passed directly to 5
the covered person at the point of sale; (3) decouple any pharmacy 6
benefits manager compensation from the cost of medications; (4) 7
prohibit any pharmacy benefits manager from charging fees for 8
formulary placement or tier-level access; (5) require that any group 9
purchasing organization that contracts with any pharmacy benefits 10
manager in this state be incorporated in the United States and that such 11
group purchasing organization disclose all fees and administrative costs 12
associated with such contracts; (6) prohibit any pharmacy benefits 13
manager from prioritizing more expensive medications over less 14
expensive and clinically appropriate medications; and (7) require that 15 Proposed Bill No. 758
LCO No. 1702 2 of 2
the Attorney General oversee pharmacy benefits manager operations in 16
this state to ensure compliance with rebate transparency and clawback 17
prohibitions and to establish a duty of care owed by pharmacy benefits 18
managers. 19
Statement of Purpose:
To reform pharmacy benefits manager practices in this state and
establish a duty of care for pharmacy benefits managers.